| Name | Title | Contact Details |
|---|
Accurate Biomed Services is a Bethany, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Coltene/Whaledent is a Cuyahoga Falls, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Engage with your audience through hand sanitizing billboards. Terraboost Media has established a network of 52,000 boards throughout the top 130 DMAs in supermarkets, drug stores, shopping malls and airports reaching an audience of over 1.4 billion per month. Brands can literally engage with their audience with a dose of wellness and by selecting the vertical networks and/or zip codes, counties that matter. QR codes, brochures, business reply cards and coupons provide advertisers with means of tracking. Join the over 180 satisfied repeat brands who continue to leverage this engaging media platform of which Arbitron research confirms 63% ad recall and 93% positive brand opinion, along with a 30% lift in purchase intent.
OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.
Orthofix Medical Inc. began in a small farmhouse in Verona Italy in 1980 when orthopedic researcher Giovanni De Bastiani recognized the bone`s natural repair capability, a concept he called “dynamization.” With that in mind, he created the first external fixation device. Today, Orthofix has grown to more than 1,200 employees with locations in the U.S., Italy, Germany, France, the U.K., Brazil, and Australia. Our products help patients in more than 70 countries around the world. The Company`s mission is to deliver innovative, quality-driven solutions as we partner with health care professionals to improve patient mobility. Headquartered in Lewisville, Texas, the company has two strategic business units: Spine and Orthopedics. Orthofix products are widely distributed via the company`s sales representatives and distributors. In addition, Orthofix is collaborating on research and development activities with leading clinical organizations such as MTF Biologics, the Orthopedic Research and Education Foundation, and the Texas Scottish Rite Hospital for Children. Orthofix makes a difference in the lives of others by providing our surgeon customers with innovative medical devices to meet the needs of their patients. Every day we are optimizing our operations, improving efficiencies, and examining our systems to provide the best support possible to our representatives, surgeons and patients.